TY - JOUR
T1 - Identifying human toxicodynamic variability
T2 - A systematic evidence map of the current knowledge
AU - Petersen, Annika Boye
AU - Bredsdorff, Lea
AU - Tahir, Natasha
AU - Niemeijer, Marije
AU - Kass, George E. N.
AU - Vitkauskaite, Aiste
AU - Moerland, Matthijs
AU - Bois, Frederic Y.
AU - Quignot, Nadia
AU - van de Water, Bob
AU - Bennekou, Susanne Hougaard
PY - 2025
Y1 - 2025
N2 - Current chemical risk assessment uses a default uncertainty factor (UF) of 3.16 for toxicodynamic (TD) variability in humans. The objective was to create a systematic evidence map (SEM) of the human variability in TD by identifying and organizing the available empirical data to assess if a further refinement of the default UF of 3.16 for TD can be achieved. PubMed and Web of Science™ were searched from 2004-2023. Studies were screened according to the eligibility criteria. Inclusion criteria included studies, where TD could be separated from toxicokinetics (TK) to exclude an impact of TK on TD variability. The literature search retrieved 2408 studies. Manual screening identified 23 in vitro studies assessing human TD variability quantitively, of which only seven in vitro studies provided quantitative estimates of a TD variability factor. No in vivo study met the inclusion criteria. Several studies found TD UF of 3.16 not covering human variability; others did. However, the data were heterogeneous, and variability in Points of Departure (PODs) and methods used to estimate TD variability complicated comparisons across studies. A standardized approach for TDVFs determination is identified. This SEM underscores the scarcity of data assessing human variability in TD, while omitting the influence of TK.
AB - Current chemical risk assessment uses a default uncertainty factor (UF) of 3.16 for toxicodynamic (TD) variability in humans. The objective was to create a systematic evidence map (SEM) of the human variability in TD by identifying and organizing the available empirical data to assess if a further refinement of the default UF of 3.16 for TD can be achieved. PubMed and Web of Science™ were searched from 2004-2023. Studies were screened according to the eligibility criteria. Inclusion criteria included studies, where TD could be separated from toxicokinetics (TK) to exclude an impact of TK on TD variability. The literature search retrieved 2408 studies. Manual screening identified 23 in vitro studies assessing human TD variability quantitively, of which only seven in vitro studies provided quantitative estimates of a TD variability factor. No in vivo study met the inclusion criteria. Several studies found TD UF of 3.16 not covering human variability; others did. However, the data were heterogeneous, and variability in Points of Departure (PODs) and methods used to estimate TD variability complicated comparisons across studies. A standardized approach for TDVFs determination is identified. This SEM underscores the scarcity of data assessing human variability in TD, while omitting the influence of TK.
KW - Chemical risk assessment
KW - Human variability
KW - Interindividual variability
KW - Toxicodynamics
KW - Default uncertainty factor
KW - Data-driven toxicodynamic variability factor
KW - Chemical specific assessment factor
U2 - 10.1016/j.yrtph.2025.105842
DO - 10.1016/j.yrtph.2025.105842
M3 - Review
C2 - 40324560
SN - 0273-2300
VL - 161
JO - Regulatory Toxicology and Pharmacology
JF - Regulatory Toxicology and Pharmacology
M1 - 105842
ER -